FIELD: biotechnology.
SUBSTANCE: aqueous composition for anaesthesia is proposed, which comprises propofol as an active agent, the PEG-660-12-hydroxystearate as a solubiliser, benzyl alcohol, or chloroethanol or parabens as preservative, the tocopherol and arginine or glycine at a specific content of components wt %. The GABA agonists can be additionally added to the composition, e.g. aminophenyl-butyric acid, local anesthetics such as lidocaine, alpha-2-adrenoceptor agonists such as xylazine. The method is proposed for implementing anaesthesia comprising administering to a patient of an effective amount of the claimed composition.
EFFECT: invention provides low toxicity of dosage form and high efficiency.
5 cl, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| READY-TO-USE INJECTION COMPOSITION FOR PREVENTING AND TREATING IRON DEFICIENCY ANAEMIA | 2016 |
|
RU2720512C1 |
| NANOSUSPENSION BASED ON ALGINATE-CHITOSAN POLYELECTROLYTE COMPLEX WITH ARTICAINE HYDROCHLORIDE FOR LOCAL ANESTHESIA | 2023 |
|
RU2806363C1 |
| ANTIBACTERIAL INJECTABLE PHARMACEUTICAL COMPOSITION | 2012 |
|
RU2512683C2 |
| GEL POSSESSING ANTI-INFLAMMATORY, IMMUNOTROPIC, ANTIALLERGIC AND WOUND HEALING ACTION | 2011 |
|
RU2457864C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTI-INFLAMMATORY, IMMUNOTROPIC, ANTIALLERGIC AND WOUND HEALING ACTION | 2011 |
|
RU2464993C1 |
| DRUG FOR TREATING OSTEOARTHROSIS (VERSIONS) | 2013 |
|
RU2538218C2 |
| PROPOFOL DELIVERY SYSTEMS | 2016 |
|
RU2709812C2 |
| INJECTION DOSAGE FORM FOR TREATING ACUTE ISCHEMIC STROKE AND CRANIOCEREBERAL INJURY, METHOD FOR PREPARING AND USING | 2009 |
|
RU2431496C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING LOCOMOTOR DISORDERS | 2013 |
|
RU2550916C1 |
| PROPOFOL STABLE CLEAR COMPOSITIONS | 2001 |
|
RU2257892C2 |
